Velocity International, Inc. v. Celerity Healthcare Solutions, Inc.

846 F. Supp. 2d 332, 2011 WL 5855013, 2011 U.S. Dist. LEXIS 133848
CourtDistrict Court, W.D. Pennsylvania
DecidedNovember 21, 2011
DocketCivil Action Nos. 09-102, 09-151
StatusPublished

This text of 846 F. Supp. 2d 332 (Velocity International, Inc. v. Celerity Healthcare Solutions, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Velocity International, Inc. v. Celerity Healthcare Solutions, Inc., 846 F. Supp. 2d 332, 2011 WL 5855013, 2011 U.S. Dist. LEXIS 133848 (W.D. Pa. 2011).

Opinion

MEMORANDUM

WILLIAM L. STANDISH, District Judge.

I

Before the Court are cross-motions for summary judgment under Fed.R.Civ.P. 56 filed by Plaintiff, Velocity International, Inc. (‘Velocity”), and Defendant, Celerity Healthcare Solutions, Inc. (“Celerity”), in connection with claims asserted by Velocity in Civil Action Nos. 09-102 and 09-151. (Docket No. 73, No. 86). In addition, Velocity and Third-Party Defendant, Philip Elias (“Elias”), move for summary judgment with respect to the counterclaims and third-party claim asserted by Celerity in this litigation. For the reasons set forth below, (1) Celerity’s motion for summary judgment on Velocity’s breach of contract claim (in Civil Action No. 09-102) relating to Celerity’s alleged liability for cancellation fees will be granted and Velocity’s cross-motion for summary judgment on this claim will be denied; (2) Celerity’s motion for summary judgment on Velocity’s Lanham Act claims (in Civil Action No. 09-151) will be granted; (3) Celerity’s motion for summary judgment on Velocity’s breach of contract claim (in Civil Action No. 09-151) relating to the limited license granted to Celerity to use Velocity’s trademarks and service marks will be granted and Velocity’s cross-motion for summary judgment on this claim will be denied; (4) Celerity’s motion for summary judgment on Velocity’s breach of contract claim (in Civil Action No. 09-151) relating to Celerity’s alleged solicitation of one of Velocity’s business partners will be granted; (5) Velocity’s request for a declaratory judgment (in Civil Action Nos. 09-102 and 09-151) will be dismissed as moot; (6) Velocity’s motion for summary judgment on Celerity’s first, second, third, fourth and sixth counterclaims will be denied; (7) Elias’s motion for summary judgment on Celerity’s fourth counterclaim will be denied; and (8) Celerity’s request for a declaratory judgment in its fifth counterclaim will be dismissed as moot.

II

The following facts are undisputed:

History and Nature of Velocity/Celerity Relationship

Velocity provides program development, production and other services for direct broadcast marketing and informational programs in various industries, including the pharmaceutical industry. (Docket No. 97, ¶ 1). The principals of Velocity are Elias, President and Chief Executive Officer (“CEO”) (Docket No. 74-2, p. 7 (Depo. p. 23)),1 Jeffrey Esswein (“Esswein”), Chief Operating Officer (“COO”) (Docket No. 77-6, p. 4 (Depo. p. 9)), and Susan Franklin (“Franklin”), Senior Vice President, Strategic Business Development (“Sr. VP”) (Docket No. 76-5, p. 4 (Depo. p. 11).

Typically, Velocity’s programs are produced at a studio in Pittsburgh and simultaneously broadcast in high definition (“HD”) to multiple locations. Velocity maintains contractual relationships with [336]*336Morton’s The Steak House (“Morton’s”) and Maggiano’s Little Italy (“Maggiano’s”) restaurants for the provision of private dining rooms at locations throughout the country in which guests can view Velocity’s invitation-only broadcasts in proprietary Velocity HD suites. (Docket No. ¶¶ 2, 10).

Velocity markets its broadcast services through two separate sales channels: direct sales and reseller sales. With regard to direct sales, companies wishing to purchase Velocity’s broadcast services deal with and enter into contracts with Velocity, and payment is made to Velocity by the end-user customer that is sponsoring the broadcast. As to reseller sales, authorized Velocity resellers purchase Velocity’s broadcast services from Velocity for resale to end-user customers, and Velocity is paid by the resellers. Resellers may sell additional complementary value-added services and may mark up the prices for Velocity’s broadcast services. Resellers also earn commissions on their sales of Velocity broadcasts. Velocity uses a uniform Rate Card for direct sales and reseller sales. (Docket No. 97, ¶¶3-7,161).

Velocity’s resellers enter into master agreements with Velocity that govern the relationship and establish payment terms for the private broadcasts purchased by the resellers for their customers. Velocity’s reseller agreements contain provisions relating to reserving and paying for the private dining rooms in the restaurants used for broadcasts. (Docket No. 97, ¶¶ 8-9).

Kurt Janson (“Janson”) and Timothy Gatzulis (“Gatzulis”) were the principals of Celerity.2 Ann O’Toole (“O’Toole”) was Celerity’s Director of Client Services. (Docket No. 81-1, pp. 6-7 (Depo. pp. 20-22)). From approximately July 2006 until September 2, 2009, Celerity was a reseller of Velocity broadcasts. During this period of time, Velocity and Celerity signed two successive master agreements that governed the terms of their relationship. The initial reseller agreement, which became effective on August 1, 2006, was signed on Velocity’s behalf by Elias and on Celerity’s behalf by Janson. (Docket No. 90-2, No. 97, ¶¶ 11-14).

Among the services to be provided by Velocity under the initial reseller agreement with Celerity were network access, event management and broadcast production (which included a set, cameras with teleprompters, a director, producer, crew and show host and make-up and wardrobe assistance). The terms of the initial reseller agreement authorized Celerity to resell Velocity’s services to Celerity’s customers in the pharmaceutical, medical and healthcare-related industries. In addition, the initial reseller agreement granted Celerity “Limited Exclusivity in the field of oncological pharmaceuticals including the field of hematology,” which meant “that Velocity will not sell directly or authorize any third party to resell Velocity Services to any clients or for any Broadcast content in or directly related to the field of oncological or hematological pharmaceuticals” during the term of the agreement. (Docket No. 90-2, pp. 1-3, No. 97, ¶¶ 16-19).

The provision in the initial reseller agreement relating to intellectual property (“IP”) rights stated:

6. General Terms and Conditions

d. All rights, title and interest not otherwise reserved by Velocity with your [337]*337prior written consent with respect to advertisements, copy, layouts, scripts, commercials, art work, designs, and other materials or documents prepared, purchased or furnished by Velocity on your behalf (“Work Product”) shall be your property (or the property of Celerity Clients per separate agreement between you and the applicable Celerity Client) and shall be “works for hire” owned by you with right of copyright and, if in Velocity’s possession, will be delivered to you upon request.3 You hereby grant to Velocity a perpetual, irrevocable, royalty-free, right and license to use, copy, distribute or transfer (“Use”) the Work Product, provided such Use is not in competition with, or materially adverse to your interests or the interests of Celerity Clients. You will obtain all necessary rights from Celerity Clients to give full force and effect to the foregoing provision, and shall indemnify Velocity to the extent set forth in section 6.e. below for any breach of this provision.

(Docket No. 80-1, p. 6).

In March 2008, Velocity and Celerity executed a new master agreement with an effective date of October 1, 2007 (“the second reseller agreement”).4 (Docket No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Edwards v. Prime, Inc.
602 F.3d 1276 (Eleventh Circuit, 2010)
Interpace Corporation v. Lapp, Inc.
721 F.2d 460 (Third Circuit, 1983)
ACUMED LLC v. Advanced Surgical Services, Inc.
561 F.3d 199 (Third Circuit, 2009)
Wicks v. Milzoco Builders, Inc.
470 A.2d 86 (Supreme Court of Pennsylvania, 1983)
Cloverleaf Development, Inc. v. Horizon Financial F.A.
500 A.2d 163 (Supreme Court of Pennsylvania, 1985)
Daniel Adams Associates, Inc. v. Rimbach Publishing, Inc.
519 A.2d 997 (Supreme Court of Pennsylvania, 1987)
Wells v. Thomas
569 F. Supp. 426 (E.D. Pennsylvania, 1983)
Dept. of Transp. v. Manor Mines, Inc.
565 A.2d 428 (Supreme Court of Pennsylvania, 1989)
DuSesoi v. United Refining Co.
540 F. Supp. 1260 (W.D. Pennsylvania, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
846 F. Supp. 2d 332, 2011 WL 5855013, 2011 U.S. Dist. LEXIS 133848, Counsel Stack Legal Research, https://law.counselstack.com/opinion/velocity-international-inc-v-celerity-healthcare-solutions-inc-pawd-2011.